Martyn Jacobs
Stock Analyst at Bell Potter
(0.04)
# 4,338
Out of 4,352 analysts
166
Total ratings
15.4%
Success rate
-21.1%
Average return
Main Sectors:
Stocks Rated by Martyn Jacobs
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: TRJ Trajan Group Holdings Limited | Maintained: Buy | $1.05 → $0.75 | $0.335 | +123.88% | 15 | May 27, 2026 | |
| ASX: EBR EBR Systems, Inc. | Maintained: Buy | $2.00 | $0.455 | +339.56% | 16 | May 21, 2026 | |
| ASX: EMV EMVision Medical Devices Ltd | Maintained: Buy | $3.15 | $1.72 | +83.14% | 8 | May 11, 2026 | |
| ASX: IPD ImpediMed Limited | Maintained: Buy | $0.03 → $0.01 | $0.007 | +42.86% | 14 | May 10, 2026 | |
| ASX: AYA Artrya Limited | Maintained: Buy | $6.10 | $4.95 | +23.23% | 2 | May 1, 2026 | |
| ASX: BIO Biome Australia Limited | Maintained: Buy | $1.00 | $0.232 | +331.03% | 16 | Apr 29, 2026 | |
| ASX: VFY Vitrafy Life Sciences Limited | Maintained: Buy | $2.25 → $3.00 | $2.55 | +17.65% | 9 | Apr 29, 2026 | |
| ASX: ONE Oneview Healthcare PLC | Maintained: Buy | $0.45 | $0.18 | +150.00% | 9 | Apr 27, 2026 | |
| ASX: MVP Medical Developments International Limited | Maintained: Buy | $0.85 | $0.385 | +120.78% | 14 | Apr 27, 2026 | |
| ASX: MVF Monash IVF Group Limited | Maintained: Hold | $0.77 → $0.75 | $0.71 | +5.63% | 5 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4.00 → $3.80 | $2.17 | +75.12% | 6 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $0.55 | $0.305 | +80.33% | 3 | Feb 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28.50 → $28.75 | $19.52 | +47.28% | 4 | Feb 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.40 | n/a | 11 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.017 | n/a | 2 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.16 | n/a | 12 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.079 | n/a | 7 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.021 | n/a | 7 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.14 | n/a | 4 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.067 | n/a | 2 | Oct 31, 2022 |
Trajan Group Holdings Limited
May 27, 2026
Maintained: Buy
Price Target: $1.05 → $0.75
Current: $0.335
Upside: +123.88%
EBR Systems, Inc.
May 21, 2026
Maintained: Buy
Price Target: $2.00
Current: $0.455
Upside: +339.56%
EMVision Medical Devices Ltd
May 11, 2026
Maintained: Buy
Price Target: $3.15
Current: $1.72
Upside: +83.14%
ImpediMed Limited
May 10, 2026
Maintained: Buy
Price Target: $0.03 → $0.01
Current: $0.007
Upside: +42.86%
Artrya Limited
May 1, 2026
Maintained: Buy
Price Target: $6.10
Current: $4.95
Upside: +23.23%
Biome Australia Limited
Apr 29, 2026
Maintained: Buy
Price Target: $1.00
Current: $0.232
Upside: +331.03%
Vitrafy Life Sciences Limited
Apr 29, 2026
Maintained: Buy
Price Target: $2.25 → $3.00
Current: $2.55
Upside: +17.65%
Oneview Healthcare PLC
Apr 27, 2026
Maintained: Buy
Price Target: $0.45
Current: $0.18
Upside: +150.00%
Medical Developments International Limited
Apr 27, 2026
Maintained: Buy
Price Target: $0.85
Current: $0.385
Upside: +120.78%
Monash IVF Group Limited
Feb 27, 2026
Maintained: Hold
Price Target: $0.77 → $0.75
Current: $0.71
Upside: +5.63%
Feb 26, 2026
Maintained: Buy
Price Target: $4.00 → $3.80
Current: $2.17
Upside: +75.12%
Feb 19, 2026
Maintained: Buy
Price Target: $0.55
Current: $0.305
Upside: +80.33%
Feb 19, 2026
Maintained: Buy
Price Target: $28.50 → $28.75
Current: $19.52
Upside: +47.28%
Oct 31, 2022
Rated: Hold
Price Target: n/a
Current: $2.40
Upside: n/a
Oct 31, 2022
Rated: Hold
Price Target: n/a
Current: $0.017
Upside: n/a
Oct 31, 2022
Rated: Hold
Price Target: n/a
Current: $3.16
Upside: n/a
Oct 31, 2022
Rated: Hold
Price Target: n/a
Current: $0.079
Upside: n/a
Oct 31, 2022
Rated: Hold
Price Target: n/a
Current: $0.021
Upside: n/a
Oct 31, 2022
Rated: Hold
Price Target: n/a
Current: $0.14
Upside: n/a
Oct 31, 2022
Rated: Hold
Price Target: n/a
Current: $0.067
Upside: n/a